A prospective cohort study to search for a risk factor of chemotherapy induced nausea and vomiting in patients with colorectal cancer.
Phase 4
Recruiting
- Conditions
- colorectal cancer
- Registration Number
- JPRN-UMIN000010165
- Lead Sponsor
- Yokohama City University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. The patient who experienced nausea or vomiting within 24 hours before giving an anticancer agent 2. Any other inadequacy for this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete response rate during 24 to 120 hours (delay phase) after an anticancer agent dosage start
- Secondary Outcome Measures
Name Time Method 1. Complete response rate during 0 to 24 hours (acute phase) and 0 to 120 hours (all phase ) after an anticancer agent dosage start 2. Complete control rate during acute phase and delay phase and all phase after an anticancer agent dosage start 3. Grade of nausea during acute phase and delay phase and all phase after an anticancer agent dosage start